A study at UC San Diego School of Medicine identified small-molecule compounds that reduced the accumulation of TDP-43, a molecular hallmark of ALS. While these preliminary findings require further investigation, it is hoped that this work may lead to new therapies for the disease. Click here to read the full article.
